Apimeds Pharmaceuticals US Inc (APUS)

$1.67 +0.04 (2.45%)
Market Cap 18.87M
Revenue (ttm) 0.00
Net Income (ttm) -1.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 17,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 11.58M
Stochastic %K 14%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 808 209 7887
Address:
2 East Broad Street, 2nd Floor, Hopewell, United States
AZOZ
AZOZ Jun. 23 at 11:08 AM
$APUS on watch for possible reversal!
0 · Reply
AZOZ
AZOZ Jun. 17 at 12:28 PM
$APUS loading zone!
0 · Reply
research_WTR
research_WTR Jun. 12 at 2:51 PM
Read Do Kim's recap following his recent podcast with Erik Emerson, CEO of @apimedsai2 (NYSE: $APUS), discussing Apitox, a purified honeybee venom, and plans for US clinical development in knee osteoarthritis (OA) and inflammatory pain. Links to the full episode are available in the report! https://www.watertowerresearch.com/doc?docID=IR_LifeSci_06102025 $APUS #Apimeds #Apitox #Osteoarthritis #Healthcare #SmallCap #Stocks #Investing #Podcast #WTRSpotlight #Biotech
0 · Reply
TimRegan_WTR
TimRegan_WTR Jun. 11 at 4:55 PM
$APUS
0 · Reply
research_WTR
research_WTR Jun. 11 at 4:42 PM
New WTR Podcast Episode Out Now! This week’s WTR Small-Cap Spotlight x WTR Biotech Spotlight crossover features $APUS CEO Erik Emerson to discuss their NYSE debut and the science behind Apitox—a purified honeybee venom being developed to treat knee osteoarthritis and multiple sclerosis. We cover: 🔹 The therapeutic potential of bee venom 🔹 Apimeds' U.S. clinical & regulatory path 🔹 A novel biotech approach to inflammatory pain 🎧 Tune in now as Tim Gerdeman & Do Kim find out how Apimeds is creating a buzz in biotech! Apple: https://podcasts.apple.com/us/podcast/apimeds-pharmaceuticals-ceo-erik-emerson-discusses/id1693448305?i=1000712447794 Spotify: https://open.spotify.com/episode/7pUcDuIOE6fdt147EezoKE?si=36772df86bd14d6f Website: https://www.watertowerresearch.com/media-detail/2115/Media $APUS #Apimeds #Biotech #SmallCap #Stocks #Inflammation #PainManagement #WTRSpotlight #Apitox #LifeScience #Healthcare #Investing
0 · Reply
Ice_Wizard
Ice_Wizard Jun. 4 at 1:52 PM
$APUS at price alert
1 · Reply
altcoinissajoke
altcoinissajoke May. 30 at 3:35 PM
$APUS CTMB might be a better play than this
0 · Reply
Ice_Wizard
Ice_Wizard May. 30 at 3:26 PM
$APUS 2.04 price alert set
0 · Reply
lukesnukes
lukesnukes May. 29 at 3:42 PM
$APUS kinda bad this debut, I doubt CTMB will be like this
0 · Reply
brijith86
brijith86 May. 28 at 7:49 PM
$APUS dont touch this Japanese scam . No institution owns it
1 · Reply
Latest News on APUS
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

May 12, 2025, 5:14 PM EDT - 6 weeks ago

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading

May 10, 2025, 12:15 AM EDT - 6 weeks ago

U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading

AHL AII ANTA ETOR

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

May 8, 2025, 5:00 PM EDT - 6 weeks ago

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO

Sep 25, 2024, 4:54 PM EDT - 9 months ago

Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO

Apimeds Pharmaceuticals US IPO Registration Document (S-1)

Sep 25, 2024, 3:14 PM EDT - 9 months ago

Apimeds Pharmaceuticals US IPO Registration Document (S-1)

AZOZ
AZOZ Jun. 23 at 11:08 AM
$APUS on watch for possible reversal!
0 · Reply
AZOZ
AZOZ Jun. 17 at 12:28 PM
$APUS loading zone!
0 · Reply
research_WTR
research_WTR Jun. 12 at 2:51 PM
Read Do Kim's recap following his recent podcast with Erik Emerson, CEO of @apimedsai2 (NYSE: $APUS), discussing Apitox, a purified honeybee venom, and plans for US clinical development in knee osteoarthritis (OA) and inflammatory pain. Links to the full episode are available in the report! https://www.watertowerresearch.com/doc?docID=IR_LifeSci_06102025 $APUS #Apimeds #Apitox #Osteoarthritis #Healthcare #SmallCap #Stocks #Investing #Podcast #WTRSpotlight #Biotech
0 · Reply
TimRegan_WTR
TimRegan_WTR Jun. 11 at 4:55 PM
$APUS
0 · Reply
research_WTR
research_WTR Jun. 11 at 4:42 PM
New WTR Podcast Episode Out Now! This week’s WTR Small-Cap Spotlight x WTR Biotech Spotlight crossover features $APUS CEO Erik Emerson to discuss their NYSE debut and the science behind Apitox—a purified honeybee venom being developed to treat knee osteoarthritis and multiple sclerosis. We cover: 🔹 The therapeutic potential of bee venom 🔹 Apimeds' U.S. clinical & regulatory path 🔹 A novel biotech approach to inflammatory pain 🎧 Tune in now as Tim Gerdeman & Do Kim find out how Apimeds is creating a buzz in biotech! Apple: https://podcasts.apple.com/us/podcast/apimeds-pharmaceuticals-ceo-erik-emerson-discusses/id1693448305?i=1000712447794 Spotify: https://open.spotify.com/episode/7pUcDuIOE6fdt147EezoKE?si=36772df86bd14d6f Website: https://www.watertowerresearch.com/media-detail/2115/Media $APUS #Apimeds #Biotech #SmallCap #Stocks #Inflammation #PainManagement #WTRSpotlight #Apitox #LifeScience #Healthcare #Investing
0 · Reply
Ice_Wizard
Ice_Wizard Jun. 4 at 1:52 PM
$APUS at price alert
1 · Reply
altcoinissajoke
altcoinissajoke May. 30 at 3:35 PM
$APUS CTMB might be a better play than this
0 · Reply
Ice_Wizard
Ice_Wizard May. 30 at 3:26 PM
$APUS 2.04 price alert set
0 · Reply
lukesnukes
lukesnukes May. 29 at 3:42 PM
$APUS kinda bad this debut, I doubt CTMB will be like this
0 · Reply
brijith86
brijith86 May. 28 at 7:49 PM
$APUS dont touch this Japanese scam . No institution owns it
1 · Reply
happy_orange
happy_orange May. 20 at 12:46 AM
$APUS recent ipo, low float bio stock that can run huge like $PTIX which recently saw a 300%+ move. Apus relatively undiscovered, can easily double from these price levels
0 · Reply
ncbc77
ncbc77 May. 19 at 6:42 PM
$TNGX $ARMP and $APUS nice move on Tango and Armata. Wholly unrelated to these two but Apimeds could make a similar move after being pushed down. IPO related.
0 · Reply
Qmaxxxx
Qmaxxxx May. 19 at 5:54 PM
$APUS runner up
0 · Reply
savasa
savasa May. 19 at 5:37 PM
$APUS is this finally moving
0 · Reply
savasa
savasa May. 16 at 8:25 PM
$APUS why RH is showing less price than Webull/Yahoo
0 · Reply
savasa
savasa May. 16 at 4:56 PM
$APUS https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-major-stock-purchase-44
0 · Reply
WarrantBuffet808
WarrantBuffet808 May. 15 at 7:52 AM
Dont be $APUS
0 · Reply
Ak2406
Ak2406 May. 14 at 7:37 PM
$APUS 💣
0 · Reply
frankyboyz
frankyboyz May. 14 at 7:21 PM
$APUS 👀 $APUS
0 · Reply
savasa
savasa May. 14 at 6:50 PM
$APUS may move from here
0 · Reply
savasa
savasa May. 14 at 6:50 PM
$APUS looks like it reached the point , volume dead
0 · Reply